Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Transplant Disorder”

1,130 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,130 results

Post-approval studies (Phase 4)Looking for participantsNCT06958796
What this trial is testing

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Who this might be right for
CytomegalovirusOrgan TransplantKidney Transplant; Complications+2 more
Camille N. Kotton, MD 80
Not applicableUnknownNCT04281797
What this trial is testing

Intestinal Microbiome Dynamics in Solid Organ and Stem Cell Transplant Recipients

Who this might be right for
Transplantation InfectionKidney Transplant; ComplicationsStem Cell Transplant Complications+2 more
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 90
Testing effectiveness (Phase 2)WithdrawnNCT00805610
What this trial is testing

Hepatocyte Transplantation in Liver Failure

Who this might be right for
Liver Failure
Virginia Commonwealth University
Not applicableUnknownNCT00147459
What this trial is testing

Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver Transplantation

Who this might be right for
Liver TransplantationHepatitis B
National Taiwan University Hospital 31
Post-approval studies (Phase 4)WithdrawnNCT04614142
What this trial is testing

Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis Access

Who this might be right for
End Stage Renal DiseaseChronic Hepatitis c
Massachusetts General Hospital
Not applicableEnrolling By InvitationNCT06061341
What this trial is testing

TruGraf Liver Gene Expression Serial Test

Who this might be right for
Autoimmune Liver DiseaseAutoimmune HepatitisPrimary Sclerosing Cholangitis+1 more
Washington University School of Medicine 20
Not applicableUnknownNCT05587556
What this trial is testing

Analysis of Clinical Outcomes and Complications in Patients Received Liver Transplantation: A Retrospective Study

Who this might be right for
Liver Transplant, Liver Cancer, Immunosuppressant
China Medical University Hospital 1,400
Testing effectiveness (Phase 2)Looking for participantsNCT06619561
What this trial is testing

Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Who this might be right for
Chronic Graft-Versus-Host Disease (cGVHD)
Deciphera Pharmaceuticals, LLC 48
Testing effectiveness (Phase 2)Looking for participantsNCT07269041
What this trial is testing

Immune Tolerance Induction After Liver Transplantation

Who this might be right for
Liver TransplantationImmune ToleranceImmune Tolerance/Drug Effects+6 more
University of California, Los Angeles 12
Not applicableUnknownNCT05051605
What this trial is testing

Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation

Who this might be right for
Liver Transplant
Ain Shams University 50
Early research (Phase 1)Study completedNCT01290172
What this trial is testing

Evaluation of Efficacy and Safety of Somatostatin Used as Inflow Modulator in Liver Transplantation.

Who this might be right for
Liver Transplant With Clinically Significant Portal Hypertension
University Hospital, Ghent 33
Testing effectiveness (Phase 2)Study completedNCT00013702
What this trial is testing

Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients

Who this might be right for
Hepatitis BHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT02595983
What this trial is testing

The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant

Who this might be right for
Transthyretin (TTR)-Mediated AmyloidosisFamilial Amyloidotic Polyneuropathy (FAP)ATTR Amyloidosis+1 more
Alnylam Pharmaceuticals 12
Early research (Phase 1)Looking for participantsNCT07077356
What this trial is testing

Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
West China Hospital 15
Post-approval studies (Phase 4)Study completedNCT04054999
What this trial is testing

Methylene Blue vs Cyanokit for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients

Who this might be right for
Vasoplegic SyndromeLiver Transplant; Complications
Mayo Clinic 19
Early research (Phase 1)Not Yet RecruitingNCT07011199
What this trial is testing

Clinical Outcomes of Early Kasai Surgery With Umbilical Cord MSCs in Biliary Atresia

Who this might be right for
Biliary AtresiaKasai PortoenterostomyMesenchymal Stem Cell Transplantation+3 more
Universitas Diponegoro 14
Not applicableActive Not RecruitingNCT06304467
What this trial is testing

CM for Patients With ALD After Liver Transplant

Who this might be right for
Alcohol Use DisorderAlcohol; LiverPost Liver Transplant+2 more
Arpan A. Patel, MD 30
Testing effectiveness (Phase 2)Ended earlyNCT00228592
What this trial is testing

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

Who this might be right for
Hepatitis BLiver Transplantation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Testing effectiveness (Phase 2)Looking for participantsNCT06725121
What this trial is testing

Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant

Who this might be right for
Hepatocellular Carcinoma (HCC)Macrovascular InvasionLiver Transplant Surgery+1 more
University Health Network, Toronto 48
Post-approval studies (Phase 4)UnknownNCT04465032
What this trial is testing

The Effect of Consecutive Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
NAFLD
Leiden University Medical Center 20
Load More Results